Assay for anti transglutaminase antibodies

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/564 (2006.01) G01N 33/573 (2006.01)

Patent

CA 2349274

A non-instrumental assay for the diagnosis of celiac disease based on the general immunochromatographic assay principles. The assay is rapid and simple and allows the reliable detection of anti transglutaminase antibodies, of both IgA and IgG isotype, in samples of human serum, plasma or blood, using as tracer the antigen transglutaminase conjugated to a colored substance, like colloidal gold or colored latex particles. The conjugated antigen is deposited onto an inert fibrous support, from where it can be released by a liquid sample. The antibodies in the sample react with the conjugated antigen developing an immunocomplex that migrates through a carrier membrane, like nitrocellulose or nylon with a pore size that allows a laminar flow of the reagents, until it reacts with the same antigen transglutaminase immobilized onto a reactive zone of the membrane. As a consequence of this reaction the immunocomplex will be trapped in the reaction site and a colored signal will be seen. Therefore a visually detectable signal in the reactive zone of the membrane indicates a positive result for the detection of anti transglutaminase antibodies in the sample.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Assay for anti transglutaminase antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Assay for anti transglutaminase antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for anti transglutaminase antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1950305

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.